Cryo-EM structures of the human glutamine transporter SLC1A5 (ASCT2) in the outward-facing conformation
Xiaodi Yu1, Olga Plotnikova1, Paul D Bonin1
1Medicine Design, Pfizer Inc, Groton, United States.
Abstract:
Alanine-serine-cysteine transporter 2 (ASCT2, SLC1A5) is the primary transporter of glutamine in cancer cells and regulates the mTORC1 signaling pathway. The SLC1A5 function involves finely tuned orchestration of two domain movements that include the substrate-binding transport domain and the scaffold domain. Here, we present cryo-EM structures of human SLC1A5 and its complex with the substrate, L-glutamine in an outward-facing conformation. These structures reveal insights into the conformation of the critical ECL2a loop which connects the two domains, thus allowing rigid body movement of the transport domain throughout the transport cycle. Furthermore, the structures provide new insights into substrate recognition, which involves conformational changes in the HP2 loop. A putative cholesterol binding site was observed near the domain interface in the outward-facing state. Comparison with the previously determined inward-facing structure of SCL1A5 provides a basis for a more integrated understanding of substrate recognition and transport mechanism in the SLC1 family.
Insights
Researchers visualized the Alanine-serine-cysteine transporter 2 (ASCT2, SLC1A5) in its outward-facing state, revealing its L-glutamine transport mechanism and potential cholesterol binding site.
Area of Science:
- Structural Biology
- Biochemistry
- Cancer Biology
Background:
- Alanine-serine-cysteine transporter 2 (ASCT2, SLC1A5) is crucial for glutamine uptake in cancer cells.
- ASCT2 regulates the mTORC1 signaling pathway, a key factor in cancer progression.
- The transporter's function relies on coordinated movements of its transport and scaffold domains.
Purpose of the Study:
- To determine the cryo-electron microscopy (cryo-EM) structures of human SLC1A5 in its outward-facing conformation.
- To elucidate the structural basis of L-glutamine transport and substrate recognition by SLC1A5.
- To investigate the role of specific structural elements, like the ECL2a loop, in the transport cycle.
Main Methods:
- Cryo-electron microscopy (cryo-EM) to obtain high-resolution structures.
- Structural analysis of human SLC1A5 in complex with L-glutamine.
- Comparative analysis with previously determined inward-facing SLC1A5 structures.
Main Results:
- Presented cryo-EM structures of human SLC1A5 in an outward-facing conformation, bound to L-glutamine.
- Revealed the conformation of the ECL2a loop, essential for domain movement during transport.
- Identified conformational changes in the HP2 loop related to substrate recognition.
- Discovered a potential cholesterol binding site near the domain interface.
Conclusions:
- The structures provide detailed insights into the SLC1A5 transport mechanism and substrate binding.
- Understanding SLC1A5 structure and function can inform cancer therapy targeting glutamine metabolism.
- Comparison of outward- and inward-facing states offers a comprehensive view of the SLC1 transporter family's mechanism.
Related Concept Videos
Secondary Active Transport
Secondary Active Transport
ABC Transporters: Exporter
Protein Translocation Machinery on the ER Membrane
Sec61 protein conducting channel
In eukaryotes, the translocon complex comprises a core heterotrimeric translocator channel called the Sec61 complex. This channel includes three transmembrane proteins, Sec61α, Sec61β, and Sec61γ, and is the largest subunit of the...
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Clathrin Coated Vesicles


